Literature DB >> 1309433

Malignant fibrous histiocytoma. A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines.

H Iwasaki1, T Isayama, Y Ohjimi, M Kikuchi, S Yoh, N Shinohara, K Yoshitake, M Ishiguro, N Kamada, M Enjoji.   

Abstract

The histogenesis of malignant fibrous histiocytoma (MFH) is controversial. To elucidate the cellular origin and characteristics of this neoplasm, the authors analyzed cell lines grown from 17 patients (15 soft tissue MFH and 2 bone MFH) by using light and electron microscopy, immunocytochemistry, enzyme cytochemistry, and functional tests for receptors for the Fc portion of immunoglobulin (Fc receptors) and immunophagocytosis. Each culture exhibited a storiform/pleomorphic pattern with mixed cellular populations consisting of spindle cells, polygonal cells, and bizarre giant cells; these morphologic features corresponded to the histologic characteristics of the primary tumors. The cells in each MFH line displayed histiocytic functional markers such as lysosomal enzymes, Fc receptors and immunophagocytosis. However, these cells differed from monocyte-derived macrophages (histiocytes) in immunoreactivity; the MFH cells expressed a mesenchymal antigen (FU3) distributed among perivascular cells and fibroblasts but demonstrated no positive reactions with Leu-M1 (CD15) and Leu-M3 (CD14), which recognize the cells of the monocyte-macrophage lineage. In conclusion, these findings suggest that MFH is not a tumor of true histiocytes but of facultative histiocytes showing mesenchymal differentiation in vitro. Chromosomal analysis performed in one MFH line demonstrated abnormal karyotypes; the modal chromosome number was 58, with 5 marker chromosomes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309433     DOI: 10.1002/1097-0142(19920115)69:2<437::aid-cncr2820690227>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Simultaneous occurrence of malignant fibrous histiocytoma and hepatocellular carcinoma in cirrhotic liver: A case report.

Authors:  Hee Sang Hwang; Nam Du Ha; Yoong Ki Jeong; Jae Hee Suh; Hye Jeong Choi; Young Min Kim; Hee Jeong Cha
Journal:  World J Hepatol       Date:  2011-09-27

2.  Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas.

Authors:  M Chang; K Tsuchiya; R H Batchelor; P S Rabinovitch; B G Kulander; R C Haggitt; G C Burmer
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

3.  FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.

Authors:  M J Perez-Bacete; A Llombart-Bosch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masako Ishiguro; Teruto Isayama; Masatoshi Naito
Journal:  J Exp Clin Cancer Res       Date:  2010-11-24

5.  Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.

Authors:  Hirofumi Nakanishi; Kiyoko Yoshioka; Susumu Joyama; Nobuhito Araki; Akira Myoui; Shingo Ishiguro; Takafumi Ueda; Hideki Yoshikawa; Kazuyuki Itoh
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

6.  Multiple tumor types appear in a transgenic mouse with the ras oncogene.

Authors:  R D Cardiff; A Leder; A Kuo; P K Pattengale; P Leder
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

7.  A Rare Entity of Undifferentiated Pleomorphic Sarcoma of the Mandible - A Case Report.

Authors:  T S Archana; Akshay Shetty; Mohammed Imran; Nida Ahmed; Praveen Kumar; T M Shruthi
Journal:  Ann Maxillofac Surg       Date:  2021-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.